These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9435899)

  • 21. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
    Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
    J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists.
    Elliott RL; Kopecka H; Tufano MD; Shue YK; Gauri AJ; Lin CW; Bianchi BR; Miller TR; Witte DG; Stashko MA
    J Med Chem; 1994 May; 37(11):1562-8. PubMed ID: 8201590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
    J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN; St-Pierre S; Gaudreau P
    J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptide.
    Cannon JB; Adjei LA; Lu MY; Garren K
    J Drug Target; 1996; 4(2):69-78. PubMed ID: 8894966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of AR-R 15849, a highly selective CCK-A agonist.
    Simmons RD; Kaiser FC; Hudzik TJ
    Pharmacol Biochem Behav; 1999 Mar; 62(3):549-57. PubMed ID: 10080250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neostriatal neurons of rats can be influenced by cholecystokinin-A receptor agonists.
    Davidowa H; Wetzel K; Henklein P
    Neuropeptides; 1997 Jun; 31(3):231-5. PubMed ID: 9243519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists.
    Padia JK; Field M; Hinton J; Meecham K; Pablo J; Pinnock R; Roth BD; Singh L; Suman-Chauhan N; Trivedi BK; Webdale L
    J Med Chem; 1998 Mar; 41(7):1042-9. PubMed ID: 9544204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist.
    Zhang J; Frassetto A; Huang RR; Lao JZ; Pasternak A; Wang SP; Metzger JM; Strack AM; Fong TM; Chen RZ
    Eur J Pharmacol; 2006 Sep; 545(2-3):147-52. PubMed ID: 16876155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR; Savastano DM; Covasa M
    Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity.
    Holladay MW; Kopecka H; Miller TR; Bednarz L; Nikkel AL; Bianchi BR; Witte DG; Shiosaki K; Lin CW; Asin KE
    J Med Chem; 1994 Mar; 37(5):630-5. PubMed ID: 8126703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation.
    Guard DB; Swartz TD; Ritter RC; Burns GA; Covasa M
    Brain Res; 2009 Apr; 1266():37-44. PubMed ID: 19232331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
    Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
    J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR; Giragossian C; Mierke DF; Jackson GE
    Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.